Published in Mol Cell Neurosci on January 01, 1996
A unique pathway for sustained neurotrophin signaling through an ankyrin-rich membrane-spanning protein. EMBO J (2004) 1.36
The beta-subunit of the hepatocyte growth factor/scatter factor (HGF/SF) receptor phosphorylates and associates with CrkII: expression of CrkII enhances HGF/SF-induced mitogenesis. Biochem J (2000) 0.75
Regulation of cell survival by secreted proneurotrophins. Science (2001) 6.32
Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature (1992) 4.46
The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science (1991) 3.86
p75 and Trk: a two-receptor system. Trends Neurosci (1995) 2.39
Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development (2000) 2.18
A molecular redox switch on p21(ras). Structural basis for the nitric oxide-p21(ras) interaction. J Biol Chem (1997) 2.08
alphavbeta5 integrin recruits the CrkII-Dock180-rac1 complex for phagocytosis of apoptotic cells. Nat Cell Biol (2000) 2.04
Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury. Proc Natl Acad Sci U S A (2004) 1.98
Redox regulation of cell signalling. Nature (1996) 1.72
Integrin-mediated activation of focal adhesion kinase is required for signaling to Jun NH2-terminal kinase and progression through the G1 phase of the cell cycle. J Cell Biol (1999) 1.71
Targeted deletion of all isoforms of the trkC gene suggests the use of alternate receptors by its ligand neurotrophin-3 in neuronal development and implicates trkC in normal cardiogenesis. Proc Natl Acad Sci U S A (1997) 1.62
High affinity nerve growth factor binding displays a faster rate of association than p140trk binding. Implications for multi-subunit polypeptide receptors. J Biol Chem (1994) 1.48
Brain-derived neurotrophic factor as a model system for examining gene by environment interactions across development. Neuroscience (2009) 1.33
Identification of an essential nonneuronal function of neurotrophin 3 in mammalian cardiac development. Nat Genet (1996) 1.30
Neurotrophins and their receptors: signaling trios in complex biological systems. Cell Mol Life Sci (2004) 1.28
The cytoplasmic and transmembrane domains of the p75 and Trk A receptors regulate high affinity binding to nerve growth factor. J Biol Chem (2001) 1.25
The epidermal growth factor. Cell Biol Int (1995) 1.25
The low-affinity p75 nerve growth factor (NGF) receptor mediates NGF-induced tyrosine phosphorylation. Proc Natl Acad Sci U S A (1991) 1.15
p75(NTR) mediates neurotrophin-induced apoptosis of vascular smooth muscle cells. Am J Pathol (2000) 1.10
TrkA immunoglobulin-like ligand binding domains inhibit spontaneous activation of the receptor. Mol Cell Biol (2000) 1.10
The adapter type protein CMS/CD2AP binds to the proto-oncogenic protein c-Cbl through a tyrosine phosphorylation-regulated Src homology 3 domain interaction. J Biol Chem (2000) 1.08
Phosphorylation of c-Crk II on the negative regulatory Tyr222 mediates nerve growth factor-induced cell spreading and morphogenesis. J Biol Chem (2000) 1.08
Expression of the v-crk oncogene product in PC12 cells results in rapid differentiation by both nerve growth factor- and epidermal growth factor-dependent pathways. Mol Cell Biol (1994) 1.08
Trk C receptor signaling regulates cardiac myocyte proliferation during early heart development in vivo. Dev Biol (2000) 1.00
Association of the Abl tyrosine kinase with the Trk nerve growth factor receptor. J Neurosci Res (2000) 0.98
Activation of Rho-dependent cell spreading and focal adhesion biogenesis by the v-Crk adaptor protein. Mol Cell Biol (1998) 0.96
NGF binding to the trk tyrosine kinase receptor requires the extracellular immunoglobulin-like domains. Mol Cell Neurosci (1995) 0.95
Phosphorylation of the IgE receptor from ionophore A23187 stimulated intact rat mast cells. Biochem Biophys Res Commun (1981) 0.94
Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II. Oncogene (2001) 0.92
Activation of c-Ha-Ras by nitric oxide modulates survival responsiveness in neuronal PC12 cells. J Biol Chem (1999) 0.91
A 31-amino-acid N-terminal extension regulates c-Crk binding to tyrosine-phosphorylated proteins. Mol Cell Biol (1993) 0.91
Immunochemical analysis of acetaminophen covalent binding to proteins. Partial characterization of the major acetaminophen-binding liver proteins. Biochem Pharmacol (1988) 0.91
Characterization of the IgE receptor isolated from human basophils. J Immunol (1979) 0.91
v-Crk-induced cell transformation: changes in focal adhesion composition and signaling. J Cell Sci (1997) 0.90
The cell surface receptor for immunoglobulin E. Effect of tunicamycin on molecular properties of receptor from rat basophilic leukemia cells. J Biol Chem (1981) 0.89
Immunohistochemical localization of Trk receptor protein in pediatric small round blue cell tumors. Am J Pathol (1993) 0.89
Phosphorylation of Crk on tyrosine 251 in the RT loop of the SH3C domain promotes Abl kinase transactivation. Oncogene (2011) 0.87
The cell surface receptor for immunoglobulin E. II. Properties of the purified biologically active receptor. J Biol Chem (1979) 0.85
v-Crk modulation of growth factor-induced PC12 cell differentiation involves the Src homology 2 domain of v-Crk and sustained activation of the Ras/mitogen-activated protein kinase pathway. J Biol Chem (1995) 0.85
Differential expression of MAG isoforms during development. J Neurosci Res (1991) 0.85
Expression of trk receptors in the developing and adult human central and peripheral nervous system. J Comp Neurol (1995) 0.85
Selective phosphorylation of the IgE receptor in antigen-stimulated rat mast cells. Proc Natl Acad Sci U S A (1983) 0.84
Trk C signaling is required for retinal progenitor cell proliferation. J Neurosci (2000) 0.84
Selective acetaminophen metabolite binding to hepatic and extrahepatic proteins: an in vivo and in vitro analysis. Toxicol Appl Pharmacol (1989) 0.84
Targeted expression of an oncogenic adaptor protein v-Crk potentiates axonal growth in dorsal root ganglia and motor neurons in vivo. Brain Res Dev Brain Res (1999) 0.83
Drug resistance results in alterations in expression of immune recognition molecules and failure to express Fas (CD95). Immunol Cell Biol (1998) 0.82
Identification of the mouse liver 44-kDa acetaminophen-binding protein as a subunit of glutamine synthetase. Toxicol Appl Pharmacol (1995) 0.79
A comparison of complaints by mild brain injury claimants and other claimants describing subjective experiences immediately following their injury. Arch Clin Neuropsychol (2001) 0.79
Immunohistochemical analysis of the neurotrophins BDNF and NT-3 and their receptors trk B, trk C, and p75 in the developing chick retina. Vis Neurosci (1998) 0.79
Purification, antibody production, and partial amino acid sequence of the 58-kDa acetaminophen-binding liver proteins. Toxicol Appl Pharmacol (1992) 0.77
A nuclear function for the tumor suppressor BRCA1. Histol Histopathol (2000) 0.76
v-Crk, an effector of the nerve growth factor signaling pathway, delays apoptotic cell death in neurotrophin-deprived PC12 cells. Cell Death Differ (1997) 0.76
Regulation of cardiac development by receptor tyrosine kinases. Trends Cardiovasc Med (1998) 0.76
Spatial distribution of indoor aerosol deposition under accidental release conditions. Health Phys (2002) 0.75
A plutonium safety training program. Health Phys (1978) 0.75
Post-treatment protection with piperonyl butoxide against acetaminophen hepatotoxicity is associated with changes in selective but not total covalent binding. Adv Exp Med Biol (1991) 0.75
Entering the domain of neurotrophin binding. Nat Biotechnol (1997) 0.75
Subcadmium fluxes in water near californium sources. Health Phys (1978) 0.75
In vivo and in vitro evidence for in situ activation and selective covalent binding of acetaminophen (APAP) in mouse kidney. Adv Exp Med Biol (1991) 0.75
Criticality safety training at a fuel examination facility. Health Phys (1981) 0.75
Disclosure of tests and raw test data to the courts: a need for reform. Neuropsychol Rev (2000) 0.75
Sampling of airborne radioactivity in a hot fuel examination facility. Health Phys (1980) 0.75
Radiation safety aspects of a hot-cell decontamination. Health Phys (1982) 0.75
The nerve growth factor receptor: biochemical and structural analysis. Recent Prog Horm Res (1989) 0.75